Stockscreener 앱 받기
190.38
0.49%
0.93
시간 외 거래:
190.38
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersMarket Risk Report & High Accuracy Trade Signal Alerts - fcp.pa.gov.br
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Will Ligand Pharmaceuticals Incorporated (LGDN) stock hit analyst forecastsJuly 2025 PostEarnings & Technical Confirmation Alerts - newser.com
Intraday pattern recognizer results for Ligand Pharmaceuticals Incorporated2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
Supplemental Annuity Collective Trust of NJ Takes $216,000 Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Short interest data insights for Ligand Pharmaceuticals Incorporated2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryQuarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com
Ligand Pharmaceuticals Incorporated stock daily chart insightsMarket Performance Report & Precise Buy Zone Tips - newser.com
Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Published on: 2025-11-05 01:39:38 - newser.com
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correction2025 Year in Review & Verified Chart Pattern Signals - newser.com
How supply chain issues affect Ligand Pharmaceuticals Incorporated stockMarket Risk Summary & Stepwise Trade Execution Plans - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higher2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Will breakout in Ligand Pharmaceuticals Incorporated lead to full recovery2025 Market Overview & Safe Entry Point Identification - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternWeekly Stock Report & Real-Time Sentiment Analysis - newser.com
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $250.00 at Oppenheimer - MarketBeat
Oppenheimer Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNXZ) Outperform Recommendation - Nasdaq
Oppenheimer Raises Price Target for Ligand Pharmaceuticals (LGND) to $250 | LGND Stock News - GuruFocus
How to use Fibonacci retracement on Ligand Pharmaceuticals Incorporated2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Oppenheimer Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation - Nasdaq
How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Yahoo Finance
Oppenheimer Raises Price Target on Ligand Pharmaceuticals to $250 From $190, Keeps Outperform Rating - MarketScreener
Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical toolsPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
What moving averages say about Ligand Pharmaceuticals Incorporated2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-02 23:44:20 - newser.com
Does Ligand Pharmaceuticals Incorporated show high probability of reboundWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com
6.82%
1.34%
자본화:
|
볼륨(24시간):